
TUROLLA ELIA ANNA
- U48, Piano: 1I, Stanza: 114
Pubblicazioni
Iannone, M., Valtorta, S., Stucchi, S., Altomonte, S., Turolla, E., Vino, E., et al. (2024). Automated radiosynthesis and preclinical evaluation of two new PSMA-617 derivatives radiolabelled via [18F]AlF2+ method. EJNMMI RADIOPHARMACY AND CHEMISTRY, 9(1) [10.1186/s41181-024-00280-0]. Dettaglio
Meazza Prina, M., Gotuzzo, I., Cazzaniga, M., De Bernardi, E., Cafaro, P., Capici, S., et al. (2023). Baseline 18FDG-PET Metabolic Tumour Volume (MTV) as a Potential Predictive Factor of Response to Metronomic Chemotherapy (mCHT) in HR+/HER2- Metastatic Breast Cancer (MBC) Patients (pts). Preliminary Results of the Metro-pet Study. Intervento presentato a: SABCS - San Antonio Breast Cancer Symposium - DEC 06-10, 2022, San Antonio, Texas, USA [10.1158/1538-7445.SABCS22-P6-01-42]. Dettaglio
Iannone, M., Stucchi, S., Turolla, E., Beretta, C., Ciceri, S., Chinello, C., et al. (2022). Synthesis and automated fluorine-18 radiolabeling of new PSMA-617 derivatives with a CuAAC radiosynthetic approach. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 65(3), 48-62 [10.1002/jlcr.3959]. Dettaglio
Monaco, L., De Bernardi, E., Bono, F., Cortinovis, D., Crivellaro, C., Elisei, F., et al. (2022). The "digital biopsy" in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 49(10), 3401-3411 [10.1007/s00259-022-05783-z]. Dettaglio
Bellucci, M., Marazzi, F., Musatti, A., Fornaroli, R., Turolla, A., Visigalli, S., et al. (2021). Assessment of anammox, microalgae and white-rot fungi-based processes for the treatment of textile wastewater. PLOS ONE, 16(3) [10.1371/journal.pone.0247452]. Dettaglio